Newsroom

Sorted by: Latest

-

Scott Machut Joins Alliant Insurance Services’ Value-Based Healthcare and Risk Management Solutions Team

IRVINE, Calif.--(BUSINESS WIRE)--Scott Machut has joined Alliant Insurance Services as Senior Vice President with the Value-Based Healthcare and Risk Management Solutions team within its Employee Benefits Group, where he will focus on strategic growth. “Scott will play an active role in expanding our value proposition for the healthcare delivery market through analytics-driven risk management solutions,” said Kevin Overbey, President, Alliant Employee Benefits. “His experience will be instrumen...
-

Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today shared the first clinical results from two of its siRNA programs for neuromuscular diseases. Early results from Phase 1/2 ascending dose studies of SRP-1001 for facioscapulohumeral muscular dystrophy type 1 (FSHD1) and SRP-1003 for myotonic dystrophy type 1 (DM1) demonstrated dose- dependent muscle exposure, early biomarker effects, and favorable tolerab...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 24.03.2026 UIGB IE00079WNSI6 8,816.00 GBP 223,576.99 25.360  ...
-

Encoded Therapeutics Announces FDA Alignment, Initiation of Pivotal Study, and ASGCT Presidential Symposium Presentation of ETX101 in Dravet Syndrome

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics, Inc. (“Encoded”), a clinical-stage biotechnology company developing precision genetic medicines for severe neurological disorders, today announced the successful completion of its Initial Comprehensive Multidisciplinary Regenerative Medicine Advanced Therapy (RMAT) meeting with the U.S. Food and Drug Administration (FDA), and alignment on the pivotal study design supporting the company’s planned BLA submission for ETX101, an AA...
-

XGS Energy and Baker Hughes Announce Strategic Collaboration to Advance Geothermal Development in New Mexico

HOUSTON--(BUSINESS WIRE)--XGS and Baker Hughes announce a strategic collaboration and initial order for engineering services to advance XGS's 150-MW geothermal project....
-

Six Flags Entertainment Appoints Richard Haddrill as Executive Chairman of the Board of Directors

CHARLOTTE, N.C.--(BUSINESS WIRE)--Six Flags Entertainment Appoints Richard Haddrill as Executive Chairman of the Board of Directors...
-

American Express Chairman and CEO Stephen J. Squeri Highlights the Company’s 2025 Performance and Position of Strength in an AI-Powered World in Letter to Shareholders

NEW YORK--(BUSINESS WIRE)--American Express Company (NYSE: AXP) today published Chairman and Chief Executive Officer Stephen J. Squeri’s annual letter to shareholders, which highlights the company’s strong performance in 2025 and its strategy to drive growth and future success in an AI-powered world. The letter is available on the American Express Newsroom, and will also be included in the company’s 2025 Annual Report posted on the Investor Relations website. ABOUT AMERICAN EXPRESS American Exp...
-

Capitolis Named to Fortune’s America’s Most Innovative Companies 2026 List

NEW YORK--(BUSINESS WIRE)--Capitolis, the financial technology company, has been named among Fortune’s America’s Most Innovative Companies in 2026. This prestigious award is presented by Fortune and Statista Inc., the world-leading statistics portal and industry ranking provider. The America’s Most Innovative Companies 2026 ranking is based on three core pillars: product innovation, process innovation, and innovation culture. To assess innovation culture and internal perspectives on process inn...
-

Otsuka Showcases New Efficacy and Safety Data of VOYXACT® (sibeprenlimab-szsi) in Patients with IgA Nephropathy (IgAN) at the 2026 ISN World Congress of Nephrology Highlighting the Impact of APRIL Inhibition

PRINCETON, N.J.--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka) today announced new analyses from the Phase 3 VISIONARY trial evaluating VOYXACT® (sibeprenlimab-szsi) in adults with IgA nephropathy (IgAN) at risk for disease progression, demonstrating clinically meaningful improvements across key markers of IgAN. These data, presented at the 2026 ISN World Congress of Nephrology (WCN’26), reinforce the potential of selectively inhibiting A PRoliferatio...
-

SLB Industrializes AI for the Energy Industry with NVIDIA

HOUSTON--(BUSINESS WIRE)--Global energy technology company SLB (NYSE: SLB) today announced an expansion of its technology collaboration with NVIDIA to design and deploy critical AI infrastructure and models for the energy industry. The work focuses on three strategic elements: Modular design for data centers: SLB will serve as the modular design partner for NVIDIA DSX AI factories. This modular approach, where components are manufactured offsite, will drive increased quality and reliability whi...